Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vasca clears FDA warning letter issues:

This article was originally published in Clinica

Executive Summary

Vasca, which develops the LifeSite haemodialysis access system, says it has resolved issues relating to a November 2001 warning letter from the FDA. Earlier this month, the Tewksbury, Massachusetts-based company became the subject of a lawsuit relating to the warning letter as well as sales of the product (see Clinica No 1019, p 13). The FDA says the company has taken appropriate corrective action, including making a labelling change for the product.

Topics

UsernamePublicRestriction

Register

MT067847

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel